
Leqembi finally secures EU clearance; Sandoz sues Amgen over Enbrel patents
Today, a brief rundown of news involving Eisai, Sarepta Therapeutics and Sandoz, as well as updates from Mural Oncology, Cyprumed and Spruce Bio that you may have missed. After a long regulatory saga, Eisai and Biogen have secured European market …